{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:03:18Z","timestamp":1740106998836,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00432-020-03387-4","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T09:04:01Z","timestamp":1599815041000},"page":"911-925","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Increase of fallopian tube and decrease of ovarian carcinoma: fact or fake?"],"prefix":"10.1007","volume":"147","author":[{"given":"Anne Kathrin","family":"H\u00f6hn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Klagges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albrecht","family":"Gl\u00e4ser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Taubenheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadja","family":"Dornh\u00f6fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Einenkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grit Gesine Ruth","family":"Hiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine E.","family":"Brambs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9775-4858","authenticated-orcid":false,"given":"Lars-Christian","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"key":"3387_CR1","doi-asserted-by":"crossref","unstructured":"ACOG Committee Opinion No. 774 Summary: opportunistic salpingectomy as a strategy for epithelial ovarian cancer prevention (2019). Obstetr Gynecol 133(4):842\u2013843","DOI":"10.1097\/AOG.0000000000003165"},{"issue":"6","key":"3387_CR2","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/1471-0528.14543","volume":"124","author":"F Chen","year":"2017","unstructured":"Chen F, Gaitskell K, Garcia MJ, Albukhari A, Tsaltas J, Ahmed AA (2017) Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review. BJOG Int J Obstetr Gynaecol 124(6):872\u2013878. https:\/\/doi.org\/10.1111\/1471-0528.14543","journal-title":"BJOG Int J Obstetr Gynaecol"},{"issue":"9760","key":"3387_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0140-6736(10)62231-3","volume":"377","author":"MP Coleman","year":"2011","unstructured":"Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C et al (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995\u20132007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377(9760):127\u2013138. https:\/\/doi.org\/10.1016\/S0140-6736(10)62231-3","journal-title":"Lancet"},{"key":"3387_CR4","doi-asserted-by":"crossref","unstructured":"Committee opinion no. 620: Salpingectomy for ovarian cancer prevention (2015). Obstetr Gynecol 125 (1):S. 279\u2013281","DOI":"10.1097\/01.AOG.0000459871.88564.09"},{"issue":"1","key":"3387_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","volume":"19","author":"CP Crum","year":"2007","unstructured":"Crum CP, Drapkin R, Miron A, Ince TA, Muto M, Kindelberger DW, Lee Y (2007) The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol 19(1):3\u20139. https:\/\/doi.org\/10.1097\/GCO.0b013e328011a21f","journal-title":"Curr Opin Obstet Gynecol"},{"key":"3387_CR6","unstructured":"Daya D, Cheung ANY, Khunamornpong S, Kim KR, Prat J, Young RH (2014) Epithelial Tumors of the M\u00fcllerian type of the Peritoneum. In: WHO classification of tumours of female reproductive organs, S. 92\u201393. Available online: https:\/\/gbv.eblib.com\/patron\/FullRecord.aspx?p=4661027. Accessed 20.08.2020"},{"issue":"9","key":"3387_CR7","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"SM Domchek","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA J Am Med Assoc 304(9):967\u2013975. https:\/\/doi.org\/10.1001\/jama.2010.1237","journal-title":"JAMA J Am Med Assoc"},{"key":"3387_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju410","author":"H Falconer","year":"2015","unstructured":"Falconer H, Yin L, Gr\u00f6nberg H, Altman D (2015) Ovarian cancer risk after salpingectomy: a nationwide population-based study. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/dju410","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"3387_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/GRF.0b013e3182480523","volume":"55","author":"B Goff","year":"2012","unstructured":"Goff B (2012) Symptoms associated with ovarian cancer. Clin Obstet Gynecol 55(1):36\u201342. https:\/\/doi.org\/10.1097\/GRF.0b013e3182480523","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"3387_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1158\/1055-9965.EPI-08-0771","volume":"18","author":"MT Goodman","year":"2009","unstructured":"Goodman MT, Shvetsov YB (2009) Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995\u20132004. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 18(1):132\u2013139. https:\/\/doi.org\/10.1158\/1055-9965.EPI-08-0771","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"issue":"10","key":"3387_CR11","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/aogs.12948","volume":"95","author":"M Gottschau","year":"2016","unstructured":"Gottschau M, Mellemkjaer L, Hannibal CG, Kjaer SK (2016) Ovarian and tubal cancer in Denmark: an update on incidence and survival. Acta Obstet Gynecol Scand 95(10):1181\u20131189. https:\/\/doi.org\/10.1111\/aogs.12948","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"3387_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0090-8258(90)90050-u","volume":"38","author":"T Gramlich","year":"1990","unstructured":"Gramlich T, Austin RM, Lutz M (1990) Histologic sampling requirements in ovarian carcinoma: a review of 51 tumors. Gynecol Oncol 38(2):249\u2013256. https:\/\/doi.org\/10.1016\/0090-8258(90)90050-u","journal-title":"Gynecol Oncol"},{"issue":"2","key":"3387_CR13","doi-asserted-by":"publisher","first-page":"172.e1","DOI":"10.1016\/j.ajog.2018.05.019","volume":"219","author":"GE Hanley","year":"2018","unstructured":"Hanley GE, Kwon JS, Finlayson SJ, Huntsman DG, Miller D, McAlpine JN (2018) Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada. Am J Obstet Gynecol 219(2):172.e1\u2013172.e8. https:\/\/doi.org\/10.1016\/j.ajog.2018.05.019","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"3387_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12282-017-0813-9","volume":"25","author":"M Harao","year":"2018","unstructured":"Harao M, Ando J, Kamata H, Hoshi N, Igarashi S, Sekiguchi R, Sugano K (2018) Peritoneal cancer arising after total abdominal hysterectomy and bilateral salpingo-oophorectomy for cervical cancer in a patient with right breast cancer and germline mutation of BRCA1 gene: a case report and literature review. Breast Cancer (Tokyo, Japan) 25(2):243\u2013249. https:\/\/doi.org\/10.1007\/s12282-017-0813-9","journal-title":"Breast Cancer (Tokyo, Japan)"},{"issue":"5","key":"3387_CR15","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.ajog.2016.07.055","volume":"215","author":"KD Hicks-Courant","year":"2016","unstructured":"Hicks-Courant KD (2016) Growth in salpingectomy rates in the United States since 2000. Am J Obstet Gynecol 215(5):666\u2013667. https:\/\/doi.org\/10.1016\/j.ajog.2016.07.055","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"3387_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrc.2016.113","volume":"17","author":"AN Karnezis","year":"2017","unstructured":"Karnezis AN, Cho KR, Gilks CB, Pearce CL, Huntsman DG (2017) The disparate origins of ovarian cancers: pathogenesis and prevention strategies. Nat Rev Cancer 17(1):65\u201374. https:\/\/doi.org\/10.1038\/nrc.2016.113","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"3387_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3802\/jgo.2013.24.2.114","volume":"24","author":"I Kulac","year":"2013","unstructured":"Kulac I, Usubutun A (2013) Microscopic lesions of fallopian tubes in endometrioid carcinoma of the endometrium: how effective are the macroscopic tubal sampling techniques? J Gynecol Oncol 24(2):114\u2013119. https:\/\/doi.org\/10.3802\/jgo.2013.24.2.114","journal-title":"J Gynecol Oncol"},{"issue":"4","key":"3387_CR18","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","volume":"186","author":"RJ Kurman","year":"2016","unstructured":"Kurman RJ, Shih I-M (2016) The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded. Am J Pathol 186(4):733\u2013747. https:\/\/doi.org\/10.1016\/j.ajpath.2015.11.011","journal-title":"Am J Pathol"},{"issue":"5","key":"3387_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/PGP.0b013e318216d447","volume":"30","author":"K Leonhardt","year":"2011","unstructured":"Leonhardt K, Einenkel J, Sohr S, Engeland K, Horn L-C (2011) p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary. Int J Gynecol Pathol Off J Int Soc Gynecol Pathol 30(5):417\u2013424. https:\/\/doi.org\/10.1097\/PGP.0b013e318216d447","journal-title":"Int J Gynecol Pathol Off J Int Soc Gynecol Pathol"},{"issue":"2","key":"3387_CR20","doi-asserted-by":"publisher","first-page":"S. 318","DOI":"10.1016\/j.ygyno.2018.01.030","volume":"149","author":"C-I Liao","year":"2018","unstructured":"Liao C-I, Chow S, Chen L-M, Kapp DS, Mann A, Chan JK (2018) Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US. Gynecol Oncol 149(2):S. 318\u2013323. https:\/\/doi.org\/10.1016\/j.ygyno.2018.01.030","journal-title":"Gynecol Oncol"},{"issue":"Iss 1 Suppl 1","key":"3387_CR21","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1097\/PGP.0000000000000552","volume":"38","author":"AE Malpica","year":"2018","unstructured":"Malpica AE, Elizabeth D, Hecht JL, Ali-Fehmi R, Quick CM, Singh N et al (2018) Endometrial carcinoma, grossing and processing issues: recommendations of the international society of gynecologic pathologists. Int J Gynecol Pathol 38(Iss 1 Suppl 1):S9\u2013S24. https:\/\/doi.org\/10.1097\/PGP.0000000000000552","journal-title":"Int J Gynecol Pathol"},{"issue":"8","key":"3387_CR22","doi-asserted-by":"publisher","first-page":"S. 1101","DOI":"10.1038\/modpathol.2015.77","volume":"28","author":"WG McCluggage","year":"2015","unstructured":"McCluggage WG, Judge MJ, Clarke BA, Davidson B, Gilks CB, Hollema H et al (2015) Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Mod Pathol Off J US Can Acad Pathol Inc 28(8):S. 1101\u20131122. https:\/\/doi.org\/10.1038\/modpathol.2015.77","journal-title":"Mod Pathol Off J US Can Acad Pathol Inc"},{"issue":"3","key":"3387_CR23","doi-asserted-by":"publisher","first-page":"S. 230","DOI":"10.1097\/PGP.0000000000000336","volume":"36","author":"WG McCluggage","year":"2017","unstructured":"McCluggage WG, Hirschowitz L, Gilks CB, Wilkinson N, Singh N (2017) The Fallopian tube origin and primary site assignment in extrauterine high-grade serous carcinoma: findings of a survey of pathologists and clinicians. Int J Gynecol Pathol Off J Int Soc Gynecol Pathol 36(3):S. 230\u2013239. https:\/\/doi.org\/10.1097\/PGP.0000000000000336","journal-title":"Int J Gynecol Pathol Off J Int Soc Gynecol Pathol"},{"issue":"2","key":"3387_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","volume":"30","author":"F Medeiros","year":"2006","unstructured":"Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C et al (2006) The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 30(2):230\u2013236. https:\/\/doi.org\/10.1097\/01.pas.0000180854.28831.77","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"3387_CR25","doi-asserted-by":"publisher","first-page":"S. 710","DOI":"10.1038\/modpathol.2016.238","volume":"30","author":"EEK Meserve","year":"2017","unstructured":"Meserve EEK, Brouwer J, Crum CP (2017) Serous tubal intraepithelial neoplasia: the concept and its application. Mod Pathol Off J US Can Acad Pathol 30(5):S. 710\u2013721. https:\/\/doi.org\/10.1038\/modpathol.2016.238","journal-title":"Mod Pathol Off J US Can Acad Pathol"},{"issue":"4","key":"3387_CR26","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/PAS.0000000000000352","volume":"39","author":"JC Morrison","year":"2015","unstructured":"Morrison JC, Blanco LZ, Vang R, Ronnett BM (2015) Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series. Am J Surg Pathol 39(4):442\u2013453. https:\/\/doi.org\/10.1097\/PAS.0000000000000352","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"3387_CR27","doi-asserted-by":"publisher","first-page":"S1201","DOI":"10.1097\/IGC.0000000000000477","volume":"25","author":"EL Moss","year":"2015","unstructured":"Moss EL, Evans T, Pearmain P, Askew S, Singh K, Chan KK et al (2015) Should all cases of high-grade serous ovarian, tubal, and primary peritoneal carcinomas be reclassified as tubo-ovarian serous carcinoma? Int J Gynecol Cancer Off J Int Gynecol Cancer Soc 25(7):S1201\u20131207. https:\/\/doi.org\/10.1097\/IGC.0000000000000477","journal-title":"Int J Gynecol Cancer Off J Int Gynecol Cancer Soc"},{"issue":"1","key":"3387_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1158\/0008-5472.CAN-15-1382","volume":"76","author":"R Perets","year":"2016","unstructured":"Perets R, Drapkin R (2016) It's totally tubula. Riding the new wave of ovarian cancer research. Can Res 76(1):10\u201317. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1382","journal-title":"Can Res"},{"issue":"3","key":"3387_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/PGP.0000000000000604","volume":"39","author":"ME Perrone","year":"2020","unstructured":"Perrone ME, Reder NP, Agoff SN, Garcia RL, Agnew KJ, Norquist BM et al (2020) An alternate diagnostic algorithm for the diagnosis of intraepithelial fallopian tube lesions. Int J Gynecol Pathol Off J Int Soc Gynecol Pathol 39(3):261\u2013269. https:\/\/doi.org\/10.1097\/PGP.0000000000000604","journal-title":"Int J Gynecol Pathol Off J Int Soc Gynecol Pathol"},{"issue":"4","key":"3387_CR30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/path.1000","volume":"195","author":"JM Piek","year":"2001","unstructured":"Piek JM, van Diest PJ, Zweemer RP, Jansen JW, Poort-Keesom RJ, Menko FH et al (2001) Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 195(4):451\u2013456. https:\/\/doi.org\/10.1002\/path.1000","journal-title":"J Pathol"},{"issue":"10","key":"3387_CR31","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","volume":"34","author":"CG Przybycin","year":"2010","unstructured":"Przybycin CG, Kurman RJ, Ronnett BM, Shih I-M, Vang R (2010) Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol 34(10):1407\u20131416. https:\/\/doi.org\/10.1097\/PAS.0b013e3181ef7b16","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"3387_CR32","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1097\/PAS.0b013e3181bc6059","volume":"33","author":"JT Rabban","year":"2009","unstructured":"Rabban JT, Krasik E, Chen L-M, Powell CB, Crawford B, Zaloudek CJ (2009) Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol. Am J Surg Pathol 33(12):1878\u20131885. https:\/\/doi.org\/10.1097\/PAS.0b013e3181bc6059","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"3387_CR33","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/PAS.0000000000000199","volume":"38","author":"JT Rabban","year":"2014","unstructured":"Rabban JT, Garg K, Crawford B, Chen L-M, Zaloudek CJ (2014) Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery. Am J Surg Pathol 38(6):729\u2013742. https:\/\/doi.org\/10.1097\/PAS.0000000000000199","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"3387_CR34","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s00432-017-2422-6","volume":"143","author":"M Rottmann","year":"2017","unstructured":"Rottmann M, Burges A, Mahner S, Anthuber C, Beck T, Grab D et al (2017) Cancer of the ovary, fallopian tube, and peritoneum: a population-based comparison of the prognostic factors and outcomes. J Cancer Res Clin Oncol 143(9):1833\u20131844. https:\/\/doi.org\/10.1007\/s00432-017-2422-6","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"3387_CR35","doi-asserted-by":"publisher","first-page":"S. 480","DOI":"10.1016\/j.jogc.2016.12.005","volume":"39","author":"S Salvador","year":"2017","unstructured":"Salvador S, Scott S, Francis JA, Agrawal A, Giede C (2017) No. 344-Opportunistic salpingectomy and other methods of risk reduction for ovarian\/fallopian tube\/peritoneal cancer in the general population. J Obstetr Gynaecol Canada JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 39(6):S. 480\u2013493. https:\/\/doi.org\/10.1016\/j.jogc.2016.12.005","journal-title":"J Obstetr Gynaecol Canada JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC"},{"issue":"3","key":"3387_CR36","doi-asserted-by":"publisher","first-page":"S. 515","DOI":"10.1016\/j.ygyno.2018.01.016","volume":"148","author":"G Samimi","year":"2018","unstructured":"Samimi G, Trabert B, Duggan MA, Robinson JL, Coa KI, Waibel E et al (2018a) Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: a survey of U.S. laboratory practices. Gynecol Oncol 148(3):S. 515\u2013520. https:\/\/doi.org\/10.1016\/j.ygyno.2018.01.016","journal-title":"Gynecol Oncol"},{"issue":"4","key":"3387_CR37","doi-asserted-by":"publisher","first-page":"pky061","DOI":"10.1093\/jncics\/pky061","volume":"2","author":"G Samimi","year":"2018","unstructured":"Samimi G, Trabert B, Geczik AM, Duggan MA, Sherman ME (2018b) Population frequency of serous tubal intraepithelial carcinoma (STIC) in clinical practice using SEE-fim protocol. JNCI Cancer Spectr 2(4):pky061. https:\/\/doi.org\/10.1093\/jncics\/pky061","journal-title":"JNCI Cancer Spectr"},{"issue":"2","key":"3387_CR38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/PGP.0000000000000123","volume":"34","author":"JD Seidman","year":"2015","unstructured":"Seidman JD (2015) Serous tubal intraepithelial carcinoma localizes to the tubal-peritoneal junction: a pivotal clue to the site of origin of extrauterine high-grade serous carcinoma (ovarian cancer). Int J Gynecol Pathol Off J Int Soc Gynecol Pathol 34(2):112\u2013120. https:\/\/doi.org\/10.1097\/PGP.0000000000000123","journal-title":"Int J Gynecol Pathol Off J Int Soc Gynecol Pathol"},{"issue":"3","key":"3387_CR39","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ygyno.2010.11.020","volume":"120","author":"JD Seidman","year":"2011","unstructured":"Seidman JD, Zhao Po, Yemelyanova A (2011) \u201cPrimary peritoneal\u201d high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer. Gynecol Oncol 120(3):470\u2013473. https:\/\/doi.org\/10.1016\/j.ygyno.2010.11.020","journal-title":"Gynecol Oncol"},{"issue":"1","key":"3387_CR40","doi-asserted-by":"publisher","first-page":"S. 7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A (2020) Cancer statistics. CA Cancer J Clin 70(1):S. 7\u201330. https:\/\/doi.org\/10.3322\/caac.21590","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3387_CR41","doi-asserted-by":"publisher","first-page":"S. 331","DOI":"10.1111\/his.12651","volume":"67","author":"N Singh","year":"2015","unstructured":"Singh N, Gilks CB, Wilkinson N, McCluggage WG (2015) Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum. Histopathology 67(3):S. 331\u2013337. https:\/\/doi.org\/10.1111\/his.12651","journal-title":"Histopathology"},{"issue":"2","key":"3387_CR42","doi-asserted-by":"publisher","first-page":"S. 195","DOI":"10.1016\/j.ygyno.2015.10.022","volume":"141","author":"N Singh","year":"2016","unstructured":"Singh N, Gilks CB, Hirschowitz L, Kehoe S, McNeish IA, Miller D et al (2016a) Primary site assignment in tubo-ovarian high-grade serous carcinoma: consensus statement on unifying practice worldwide. Gynecol Oncol 141(2):S. 195\u2013198. https:\/\/doi.org\/10.1016\/j.ygyno.2015.10.022","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3387_CR43","doi-asserted-by":"publisher","first-page":"S. 230","DOI":"10.1097\/PGP.0000000000000270","volume":"35","author":"N Singh","year":"2016","unstructured":"Singh N, Gilks CB, Hirshowitz L, Wilkinson N, McCluggage WG (2016b) Adopting a uniform approach to site assignment in tubo-ovarian high-grade serous carcinoma: the time has come. Int J Gynecol Pathol Off J Int Soc Gynecol Pathol 35(3):S. 230\u2013237. https:\/\/doi.org\/10.1097\/PGP.0000000000000270","journal-title":"Int J Gynecol Pathol Off J Int Soc Gynecol Pathol"},{"issue":"3","key":"3387_CR44","doi-asserted-by":"publisher","first-page":"S. 339","DOI":"10.1111\/his.13248","volume":"71","author":"N Singh","year":"2017","unstructured":"Singh N, McCluggage WG, Gilks CB (2017) High-grade serous carcinoma of tubo-ovarian origin: recent developments. Histopathology 71(3):S. 339\u2013356. https:\/\/doi.org\/10.1111\/his.13248","journal-title":"Histopathology"},{"key":"3387_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10120468","author":"TR Soong","year":"2018","unstructured":"Soong TR, Kolin DL, Teschan NJ, Crum CP (2018) Back to the future? The fallopian tube, precursor escape and a dualistic model of high-grade serous carcinogenesis. Cancers. https:\/\/doi.org\/10.3390\/cancers10120468","journal-title":"Cancers"},{"issue":"3","key":"3387_CR46","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ygyno.2015.01.534","volume":"136","author":"RD S\u00f8rensen","year":"2015","unstructured":"S\u00f8rensen RD, Schnack TH, Karlsen MA, H\u00f8gdall CK (2015) Serous ovarian, fallopian tube and primary peritoneal cancers: a common disease or separate entities\u2014a systematic review. Gynecol Oncol 136(3):571\u2013581. https:\/\/doi.org\/10.1016\/j.ygyno.2015.01.534","journal-title":"Gynecol Oncol"},{"issue":"7","key":"3387_CR47","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/jnci\/djx263","volume":"110","author":"B Trabert","year":"2018","unstructured":"Trabert B, Coburn SB, Mariani A, Yang HP, Rosenberg PS, Gierach GL et al (2018) Reported incidence and survival of fallopian tube carcinomas: a population-based analysis from the North American association of central cancer registries. J Natl Cancer Inst 110(7):750\u2013757. https:\/\/doi.org\/10.1093\/jnci\/djx263","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"3387_CR48","doi-asserted-by":"publisher","first-page":"S697","DOI":"10.1158\/1940-6207.CAPR-18-0009","volume":"11","author":"K Visvanathan","year":"2018","unstructured":"Visvanathan K, Shaw P, May BJ, Bahadirli-Talbott A, Kaushiva A, Risch H et al (2018a) Fallopian tube lesions in women at high risk for ovarian cancer: a multicenter study. Cancer Prev Res (Philadelphia, Pa.) 11(11):S697\u2013706. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-18-0009","journal-title":"Cancer Prev Res (Philadelphia, Pa.)"},{"issue":"7","key":"3387_CR49","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1093\/jnci\/djx269","volume":"110","author":"K Visvanathan","year":"2018","unstructured":"Visvanathan K, Wang T-L, Shih I-M (2018b) Precancerous lesions of ovarian cancer\u2014a US perspective. J Natl Cancer Inst 110(7):692\u2013693. https:\/\/doi.org\/10.1093\/jnci\/djx269","journal-title":"J Natl Cancer Inst"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03387-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-020-03387-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03387-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T01:20:57Z","timestamp":1631323257000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-020-03387-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["3387"],"URL":"https:\/\/doi.org\/10.1007\/s00432-020-03387-4","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"type":"print","value":"0171-5216"},{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[2020,9,11]]},"assertion":[{"value":"20 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}